GCC Generic Drug Market

1   Preface
2   Scope and Methodology
    2.1   Objectives of the study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Generic Drug Industry
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Breakup by Region
    5.4    Market Breakup by Drug Delivery
    5.5    Market Forecast
6   GCC Generic Drug Industry 
    6.1    Market Overview
    6.2    Market Performance
    6.3    Impact of COVID-19
    6.4    Market Breakup by Region
    6.5    Market Forecast
    6.6   SWOT Analysis
        6.6.1 Overview
        6.6.2 Strengths
        6.6.3 Weaknesses
        6.6.4 Opportunities
        6.6.5 Threats 
    6.7    Value Chain Analysis
        6.7.1 Overview
        6.7.2 Research and Development
        6.7.3 Raw Material Procurement
        6.7.4 Manufacturing
        6.7.5 Marketing
        6.7.6 Distribution
    6.8   Porter’s Five Forces Analysis
        6.8.1 Overview
        6.8.2 Bargaining Power of Buyers
        6.8.3 Bargaining Power of Suppliers
        6.8.4 Degree of Competition
        6.8.5 Threat of New Entrants
        6.8.6 Threat of Substitutes
    6.9    Key Success and Risk Factors for Manufacturers
7   Performance of Key Regions
    7.1    Saudi Arabia 
        7.1.1 Market Performance
        7.1.2 Market Forecast
        7.1.3 Key Players
        7.1.4 Regulatory Process for Generics Drug Industry in Saudi Arabia
    7.2     UAE
        7.2.1 Market Performance
        7.2.2 Market Forecast
        7.2.3 Key Players
        7.2.4 Regulatory Process for Generics Drug Industry in UAE
    7.3     Kuwait
        7.3.1 Market Performance
        7.3.2 Market Forecast
        7.3.3 Regulatory Process for Generics Drug Industry in Kuwait
    7.4    Qatar
        7.4.1 Market Performance
        7.4.2 Market Forecast
        7.4.3 Regulatory Process for Generics Drug Industry in Qatar
    7.5   Bahrain
        7.5.1 Market Performance
        7.5.2 Market Forecast
        7.5.3 Regulatory Process for Generics Drug Industry in Bahrain
    7.6   Oman
        7.6.1 Market Performance
        7.6.2 Market Forecast
        7.6.3 Regulatory Process for Generics Drug Industry in Oman
8   Competitive Landscape
    8.1    Market Structure
    8.2    Market Share of Key Players
9   Generic Drug Manufacturing Process
    9.1    Product Overview
    9.2    Detailed Process Flow 
    9.3    Various Types of Unit Operations Involved
    9.4    Mass Balance and Raw Material Requirements
10  Project Details, Requirements and Costs Involved
    10.1    Land Requirements and Expenditures
    10.2    Construction Requirements and Expenditures
    10.3    Plant Machinery
    10.4    Machinery Pictures
    10.5    Raw Material Requirements and Expenditures
    10.6    Packaging Requirements and Expenditures
    10.7    Transportation Requirements and Expenditures
    10.8    Utility Requirements and Expenditures
    10.9    Manpower Requirements and Expenditures
    10.10   Other Capital Investments
11  Loans and Financial Assistance
12  Project Economics
    12.1    Capital Cost of the Project
    12.2    Techno-Economic Parameters
    12.3    Product Pricing and Margins across Various Levels of the Supply Chain
    12.4    Taxation and Depreciation
    12.5    Income Projections
    12.6    Expenditure Projections
    12.7    Financial Analysis
    12.8    Profit Analysis
13  Key Player Profiles
 
List of Figures

Figure 1: GCC: Generic Drug Market: Key Market Drivers and Challenges
Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2018-2023
Figure 3: Global: Generic Drug Market: Breakup by Region (in %), 2023
Figure 4: Global: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 5: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2024-2032
Figure 6: GCC: Generic Drug Market: Sales Value Trends (in Billion US$), 2018-2023
Figure 7: GCC: Generic Drug Market: Breakup by Region (in %), 2023
Figure 8: GCC: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2024-2032
Figure 9: GCC: Generic Drug Industry: SWOT Analysis
Figure 10: GCC: Generic Drug Industry: Value Chain Analysis
Figure 11: GCC: Generic Drug Industry: Porter’s Five Forces Analysis
Figure 12: Saudi Arabia: Generic Drug Market: Sales Value Trends (in Million US$), 2018-2023
Figure 13: Saudi Arabia: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2024-2032
Figure 14: Saudi Arabia: Generic Drug Market: Breakup by Key Players (in %), 2023
Figure 15: UAE: Generic Drug Market: Sales Value Trends (in Million US$), 2018-2023
Figure 16: UAE: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2024-2032
Figure 17: UAE: Generic Drug Market: Breakup by Key Players (in %), 2023
Figure 18: Kuwait: Generic Drug Market: Sales Value Trends (in Million US$), 2018-2023
Figure 19: Kuwait: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2024-2032
Figure 20: Qatar: Generic Drug Market: Sales Value Trends (in Million US$), 2018-2023
Figure 21: Qatar: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2024-2032
Figure 22: Bahrain: Generic Drug Market: Sales Value Trends (in Million US$), 2018-2023
Figure 23: Bahrain: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2024-2032
Figure 24: Oman: Generic Drug Market: Sales Value Trends (in Million US$), 2018-2023
Figure 25: Oman: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2024-2032
Figure 26: GCC: Generic Drug Market: Breakup by Key Players (in %), 2023
Figure 27: Generic Drug Manufacturing: Detailed Process Flow
Figure 28: Generic Drug Manufacturing Process: Conversion Rate of Products
Figure 29: Generic Drug Manufacturing Plant: Breakup of Capital Costs (in %)
Figure 30: Generic Drug Industry: Profit Margins at Various Levels of the Supply Chain
Figure 31: Generic Drug Production: Manufacturing Cost Breakup (in %)
Figure 32: Generic Drug Production: Price Structure Analysis 
 
List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2023 and 2032
Table 2: GCC: Generic Drug Market: Key Industry Highlights, 2023 and 2032
Table 3: GCC: Generic Drug Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 4: Generic Drug Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 5: Generic Drug Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 6: Generic Drug Manufacturing Plant: Costs Related to Machinery (in US$)
Table 7: Generic Drug Manufacturing Plant: Raw Material Requirements
Table 8: Generic Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 9: Generic Drug Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 10: Details of Financial Assistance Offered by Financial Institutions
Table 11: Generic Drug Manufacturing Plant: Capital Costs (in US$)
Table 12: Generic Drug Manufacturing Plant: Techno-Economic Parameters
Table 13: Generic Drug Manufacturing Plant: Taxation and Depreciation
Table 14: Generic Drug Manufacturing Plant: Income Projections (in US$)
Table 15: Generic Drug Manufacturing Plant: Expenditure Projections (in US$)
Table 16: Generic Drug Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 17: Generic Drug Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
Table 18: Generic Drug Manufacturing Plant: Profit and Loss Account